All In Nutritionals
Facebook Instagram Linkedin Twitter Website
Home Blog Page 169

MusclePharm launches allergen-free, vegan line

By
Editor
-
0
MusclePharm launches allergen-free

MusclePharm, a scientifically-driven, performance lifestyle sports nutrition company, has launched its Natural Series. This line of plant-based, vegan, gluten-free, soy-free, non-GMO, premium products targets individuals seeking an organic alternative to traditional nutritional products and supplements.

 

The new line launched at Natural Products Expo West, the world’s largest natural products event. These products complement MusclePharm’s existing range of premium-quality products, and represents a new retail category for the company, which made its name as a leader in the sports nutrition industry.

 

“Natural Series represents both a logical extension and a tremendous opportunity for MusclePharm to capitalize on the brand recognition and consumer acceptance of our products,” says Ryan Drexler, CEO and chairman of the board for MusclePharm. “In addition, the launch underscores our commitment to providing our customers with high-quality products that support their diverse fitness needs and goals.”

 

Adds Drexler, “From professional athletes to weekend warriors, we strive to cater to every subset of the active population and offer scientifically-proven products that optimize results. We are expanding our line in response to the burgeoning demand for nutritious, all-natural organic offerings that promote healthy lifestyles and environmental sustainability.”

 

Select items in the Natural Series are certified USDA Organic, denoting third-party verification of their quality and purity, and demonstrating best practices and careful stewardship. These include:

 

  • MusclePharm USDA Organic Plant-Based Performance Protein – a blend of raw, all-organic protein sourced from Pea Protein isolate, and QuinoaTrim™ Quinoa – delivering all essential amino acids to support daily nutrition and performance.
  • MusclePharm USDA Organic Superfoods – a combination of organic greens, fruits and vegetables, ancient grains, and sprouted whole foods that serve any active lifestyle. To maximize these superfoods’ power, aloe vera, a full spectrum of digestive enzymes, and probiotics, help promote superior digestion and bioavailability.
  • MusclePharm Organic Protein Bars – featuring complete proteins sourced from organic whole-grain brown rice protein, and organic pea protein, to provide all the beneficial lean muscle-building benefits of protein through an all-natural, organic, and great-tasting small meal alternative.
  • MusclePharm Pre-Workout – a combination of caffeine, natural botanicals, electrolytes, and Amino Acids that work together to support training goals and provide pure, unadulterated results, naturally.

 

According to Zion Market Research, the global dietary supplements market continues to expand and is expected to reach $220.3 billion in 2022, while the Organic Trade Association (OTA) notes that the organic industry is also experiencing unprecedented growth, up 11 percent (for a total of $43.3 billion) in 2015.

 

“Both the all-natural and organic segments represent the fastest-growing corner of the market, and MusclePharm is a brand uniquely positioned to capitalize on this opportunity,” adds Drexler. “Over the past year, we have worked closely with regulatory bodies to secure USDA Organic certification for a majority of these products, which not only differentiates the Natural Series from its competitors, but effectively positions MusclePharm to further penetrate its existing distribution channels and enter new markets.”

 

About MusclePharm Corporation

 

MusclePharm® is a scientifically-driven, performance lifestyle company that develops, manufactures, markets and distributes branded nutritional supplements. The Company offers a range of powders, capsules, tablets and gels. Its portfolio of recognized brands includes MusclePharm® Sport Series, Black Label and Core Series, and FitMiss™, which are available in more than 120 countries and over 50,000 retail outlets worldwide. The clinically-proven supplements are developed through a six-stage research process utilizing the expertise of leading nutritional scientists, doctors and universities. MusclePharm is the innovator of the sports nutrition industry. For more information, visit http://www.musclepharm.com. To sign up to receive MusclePharm news via email, please visit http://ir.musclepharmcorp.com/email-alerts.

Could probiotics be the next trend in the aging market?

By
Editor
-
0

According to a new systematic review, probiotics may enhance cellular immune activity in healthy elderly adults.
Four clinical trials were included in this analysis. Data showed that B. lactis HN019™, a product from DuPont Nutrition and Health’s Danisco® range, was highly efficacious in increasing polymorphonuclear (PMN) phagocytic capacity and natural killer (NK) cell tumoricidal activity.
“This is the first Systematic Review and meta-analysis of the probiotic strain Bifidobacterium animalis ssp. lactis HN019™ in relation to immune function in elderly – a highly relevant target group since elderly people have increased susceptibility to infections and cancer that are associated with decline in cellular immune function,” said Liisa Lehtoranta, research manager, DuPont Nutrition & Health.
Elderly people represent the fastest growing population globally. Typically, the elderly population has weaker immune responses to vaccination and elevated risk for infections, certain autoimmune diseases, and cancer. Several of these health risks are a consequence of weakening immune function associated with the aging process, also known as immunosenescence. Gut microbiota plays a significant role in immunosenescence, and is influenced by physiological aging process, lifestyle, and diet.
Research shows that gut microbiota of the elderly has specific features compared to microbiota of younger adults, such as lower levels of bifidobacteria and higher levels of Bacteroidetes spp. These changes in microbiota composition may be indicative of dysbiosis and poorer health. As such, targeted dietary interventions which restore microbiota composition could potentially help maintain overall health and improve the quality of the life of the elderly.

Cross-border e-commerce more susceptible to fraud

By
Editor
-
0
Cross-border e-commerce more susceptible to fraud

According to data by Radial, cross-border ecommerce is proven to be much more susceptible to fraud than domestic ecommerce. The data, which covers over 100 clients in eight different verticals and over 100 million transactions, showed that cross-order ecommerce was riskier. LexisNexis data confirms that international online/mobile channels suffer 2.5 times more successful fraud than domestic-only remote channels.

 

Cleveland Brown, CEO of leading global payment processing provider Payscout, Inc., said these findings underscore the importance of risk analysis and fraud management for global ecommerce merchants.

 

According to Business Insider, U.S. retailers lost roughly $32 billion to fraud in 2014—a 39 per cent increase over the $23 billion in fraud losses the prior year. LexisNexis reports that international merchants with ecommerce/mcommerce transactions have the highest fraud costs as a percentage of annual revenues; their costs are nearly 22 per cent higher than the average multi-channel merchant, and 85 per cent higher than international merchants that operate physical stores only.

 

“While fraud remains an ongoing challenge for all retailers, these findings suggest that cross-border merchants should be particularly diligent in their efforts to combat fraud—both to prevent financial losses and to reassure consumers their data is secure,” said Brown. “This means addressing fraud on multiple fronts and using layered solutions.”

 

International merchants contend with several types of fraud; those with e/mcommerce channels attributed 30 per cent of their losses to friendly fraud, 30 per cent to lost or stolen merchandise, 22 per cent to identity theft and 17 per cent to fraudulent requests for return/refund.

 

Retailers also have to protect their customers’ information from cyber-attacks and data breaches, and they need to avoid declining legitimate transactions on suspicion of fraud. Among large cross-border merchants, 31 per cent of declined transactions turned out to be false positives.

 

The good news is that multi-layered fraud solutions have the potential to reduce false positives from roughly 1 in 3 to 1 in 5, and to cut the average monthly number of successful fraud attempts by more than half. Brown notes that international merchants can mitigate their fraud risk by starting with a secure payment system and building on that foundation with comprehensive online fraud protection. By providing global payment solutions for merchants in all risk verticals, Payscout has built a best-in-class suite of fraud protection tools that can support any global entrepreneur.

 

“Effective fraud management is every bit as important to a web-based business’ success as transaction and payment processing,” Brown explained. “That’s why in addition to providing ecommerce merchants with a robust, flexible and secure payment infrastructure, Payscout assists them with advanced fraud protection solutions.”

 

Payscout’s managed risk analysts support thousands of clients on six continents with a range of proven tools and strategies, from automated fraud screening and manual reviews to risk management assessments and performance audits. “We maintain a global knowledge network that helps identify new fraud trends before they impact our clients’ businesses, ultimately enabling ecommerce merchants to accept more good orders and reduce their risk of fraud,” concluded Brown.

Could immunotherapy cure brain cancer?

By
Editor
-
0

A promising combination of immunotherapies delivers a one-two punch to brain cancer tumours with high cure rates in mice, scientific evidence published in Nature Communications says.

Researchers at the Children’s Hospital of Eastern Ontario (CHEO) in Ottawa found that a combination of drugs known as SMAC Mimetics and immune checkpoint inhibitors (ICIs) amplifies kill rates of cancer tumour cells in laboratory testing. Researchers also discovered a new mechanism by which the combination promotes long-term immunity against glioblastoma tumours. The combination therapy also proved to be highly effective against breast cancer and multiple myeloma.

“These findings represent a significant evolution in our research and the field of immunotherapy. We are the first in the world to show the synergistic tumour-killing impact of combining SMAC Mimetics with immune checkpoint inhibitors for glioblastoma,” said Dr. Robert Korneluk, distinguished professor at the University of Ottawa and senior scientist at the CHEO Research Institute. “You could say it takes two to tango. We believe that it takes a combination strategy to impact cancer cure rates.”

In 2014, a team of scientists led by Dr. Korneluk discovered that combining SMAC Mimetics with immune stimulators or live virus therapies had a synergistic or amplified tumour-killing effect that was greater than either agent on its own. Today’s news shows that SMAC Mimetics also have a powerful synergistic effect with ICIs, relatively new drugs that are showing great promise in the clinic. SMAC Mimetics known as LCL161 and Birinapant were combined with ICI antibodies targeting PD-1 and CTLA-4 immune checkpoints.

Eric Lacasse, a scientist at the CHEO Research Institute, said: “Two drug companies have initiated human clinical trials this year to assess the impact of this combination of SMAC Mimetics and ICIs on patients with a variety of cancers. Although it could be years before any clinical trials begin for adults or children with the deadly brain cancer, glioblastoma, we’re looking forward to seeing how scientific evidence from these experimental treatments adds to our knowledge. It’s an exciting, exploratory field and we hope we’ve hit a home run.”

Shawn Beug, lead author of the 2014 and 2017 papers, said: “This research heightens our understanding of the mechanics behind this double-whammy effect, which both enhances the immune response and weakens tumour cells to immune attack. We’re hoping that more oncologists and biotech companies test out this combination in clinical trials as we continue to decipher how SMAC Mimetics encourage the immune system to kill cancer cells.”

The research was funded by the Canadian Cancer Society Research Institute, Brain Canada (with financial support from Health Canada through the Canada Brain Research Fund) and the Canadian Institutes of Health Research. In addition, the work was supported by donations to the Ottawa Regional Cancer Foundation, the Kiwanis Medical Foundation and the CHEO Foundation.

The University of Ottawa—A crossroads of cultures and ideas
The University of Ottawa is home to over 50,000 students, faculty and staff, who live, work and study in both French and English. Our campus is a crossroads of cultures and ideas, where bold minds come together to inspire game-changing ideas. We are one of Canada’s top 10 research universities—our professors and researchers explore new approaches to today’s challenges. One of a handful of Canadian universities ranked among the top 200 in the world, we attract exceptional thinkers and welcome diverse perspectives from across the globe.

About the CHEO Research Institute
The CHEO Research Institute coordinates the research activities of the Children’s Hospital of Eastern Ontario (CHEO) and is affiliated with the University of Ottawa. Its three programs of research include molecular biomedicine, health information technology, and evidence to practice research. Key themes include cancer, diabetes, obesity, mental health, emergency medicine, musculoskeletal health, electronic health information and privacy, and genetics of rare disease. The CHEO Research Institute makes discoveries today for healthier kids tomorrow. For more information, visit www.cheori.org.

Nestlé baby biscuits found to contain excess acrylamide

By
Editor
-
0

A French study found that Nestlé’s P’tit Biscuits contain levels of acrylamide—a chemical contaminant known to increase the risk of cancer—that are over the European benchmark levels.

The survey, carried out by three non-profit organizations—SumOfUs, Changing Markets and MECF Network—found that the Nestlé biscuits contained 226.1 micrograms per kilogram of acrylamide, which is above the EU benchmark level of 200 micrograms per kilogram.

Acrylamide forms naturally when starchy foods are fried or roasted, and is found both in home-cooked foods as well as processed foods. As such, while acrylamide cannot be avoided entirely, you should do all you can to limit exposure.

Health Canada has yet to make a statement on the issue.

Excess milk intake may shorten life span in women

By
Editor
-
0

According to new research out of Sweden, drinking excess milk may shorten life span in women.

The team, which operated out of Uppsala University and Karolinska Institute, found that large volumes of milk can promote chronic low-grade inflammation in the body—especially in women. However, they also discovered that adequate fruit and vegetable intake can provide a degree of protection against this damage.

High milk consumption was defined by scientists as three or more glasses of milk per day. Fruits and vegetables are able to combat the related inflammation due to their antioxidant and anti-inflammatory powers.

Moreover, while milk has been long marketed as necessary to bone health, the study demonstrated a higher risk of fractures in women with high daily milk consumption. The team also identified higher mortality rates in both women and men that consumed large quantities of milk.

Could gut bacteria play a role in Alzheimer’s disease?

By
Editor
-
0

A new study out of Sweden’s Lund University has found a possible relationship between gut bacteria and the development of Alzheimer’s. According to researchers, intestinal bacteria can accelerate the development of the disease.

Through the study of both healthy and diseased mice, the researchers noticed that mice suffering from Alzheimer’s had a different composition of gut bacteria than healthy subjects. To clarify the link between these variables, the researchers transferred intestinal bacteria from diseased mice to healthy ones. They discovered that mice with the diseased bacteria developed more beta-amyloid plaques.

“Our study is unique as it shows a direct causal link between gut bacteria and Alzheimer’s disease. It was striking that the mice which completely lacked bacteria developed much less plaque in the brain,” says researcher Frida Fåk Hållenius, at the Food for Health Science Centre.

“The results mean that we can now begin researching ways to prevent the disease and delay the onset. We consider this to be a major breakthrough as we used to only be able to give symptom-relieving antiretroviral drugs.”

The researchers will continue to study the role of bacteria in the development of Alzheimer’s disease. They also plan to test entirely new types of preventive and therapeutic strategies based on the modulation of the gut microbiota through diet and new probiotics.

How should you really be treating gout?

By
Editor
-
0

Because gout is the most common inflammatory arthritis worldwide, chances are that some of your patients are suffering from it. This ailment is caused by the crystallization of uric acid in the blood, deposits of which can cause severe joint pain and nodules in the skin.

However, proper treatment options for gout have long been disputed. In 2012, the American College of Rheumatology released treatment guidelines for the disease, suggesting that uric acid levels should be lowered to below 6mg/dL and constantly monitored. The American College of Physicians (ACP), however, suggests that a “treat-to-avoid-symptoms” approach to gout may be reasonable, anti-inflammatory drugs do not treat the underlying issues with uric acid content.

This week, in the Annals of Internal Medicine, Tuhina Neogi, MD, PhD, professor of medicine at Boston University School of Medicine (BUSM), suggests that uric acid should be lowered to below the level at which it crystalizes in the blood (6.8mg/dL).

In order to help your patients and clients control their gout, advise that they make certain lifestyle changes. By avoiding fructose, limiting alcohol, eating foods high in purine (like red meat, seafood, and organ meats), exercising, and keeping hydrated, they can avoid gout flare-ups. Moreover, apple cider vinegar helps to break down and eliminate uric acid, as it contains malic acid.

Canada’s Health Coalitions warn of cuts to health care

By
Editor
-
0

Canada’s Health Coalitions signed a joint statement and held a media conference today on the recent bilateral health care deals and called for a united health accord.

Since late December, the federal government has abandoned a national health accord negotiation and is now signing bilateral health deals with the provinces and territories. These deals will not fund public health care at the necessary levels to maintain today’s public services. Canada’s Health Coalitions are calling for a national health accord which ensures everyone can access needed health care services in accordance with the Canada Health Act.

“The health coalitions are deeply concerned about the future of Canada’s universal, single-tier public health care system,” said Adrienne Silnicki, national coordinator, Canadian Health Coalition. “Today the Coalitions are warning that the bilateral deals will likely lead to cuts in public health care, further inequality across the country, and a reduced authority of the federal government to uphold the Canada Health Act,” said Mary Boyd, PEI Health Coalition.

Across the country, the health coalitions are sharing their concerns about how the bilateral deals will affect the people in their provinces and territories.

“The provinces and territories simply can’t afford to shoulder the proposed federal cut to the funding formula,” said Natalie Mehra, Executive Director, Ontario Health Coalition. “We are also deeply concerned the federal minister’s proposed ‘transformation’ will lead to damaging cuts to public hospitals. Funding needs to meet projected population need for hospital care and we need to create a continuum of public health care for the aging and chronically ill.”

“In Saskatchewan we’re very worried about a deal that underfunds health care. But we’re additionally concerned that the provincial and federal government have worked out a deal to allow wealthy Saskatchewanians to jump the queue and get health care services faster than the rest,” said Leading Eagle Man, Chair, Saskatchewan Health Coalition. “We want to see the Federal government uphold their commitment to the Canada Health Act and for Minister Philpott to make good on her warnings to Saskatchewan that they must deliver care in accordance with the principles of the Act.”

“Nova Scotia was one of the first provinces to sign the deal. The problems we’re facing with an aging population, and few resources especially in our rural communities will only be exacerbated by signing a deal that cuts current federal contributions almost in half,” said Chris Parsons, coordinator, Nova Scotia Health Coalition.

“The reality is that tying health care to GDP means that when we need health care the most, we have the fewest resources to pay for it,” said Rick Turner, Co-Chair of the BC Health Coalition. Turner urged the federal, provincial, territorial and First Nations governments to return to the negotiating table: “We need a health accord to unite the country in recommitting to a shared vision and framework for improving health care for everyone in Canada.”

Giant Tiger to open 16th location in Ottawa/Gatineau

By
Editor
-
0
Giant Tiger to open 16th location in Ottawa/Gatineau

Giant Tiger Stores Limited is pleased to announce the opening of its newest location in the National Capital Region. This new store will be located at 1512 Merivale Road and will occupy approximately 23,000 square feet of retail space. It is scheduled to open on July 8, 2017.

 

This is the 16th location in the Ottawa-Gatineau area. The all-Canadian retailer was founded in 1961 in Ottawa’s Byward Market. That historic location is still in operation today and stands as a reminder of Giant Tiger’s entrepreneurial and Canadian roots.

 

“We are pleased to be bringing another Giant Tiger store to Ottawa,” says Thomas Haig, President and COO of Giant Tiger Stores Limited. “This location will not only be our 16thstore in Ottawa/ Gatineau but will mark the opening of our 232nd store. This new location will bring our unique shopping experience, everyday low prices, and exceptional customer service to this vibrant Ottawa neighborhood.”

 

Giant Tiger is proud to make a difference in the communities we call home by building lasting relationships with local organizations to benefit causes that affect customers and communities directly. Annually, Giant Tiger Stores Limited donates more than $2 million to more than 700 community associations and charities across Canada. Giving back is deeply rooted in the corporate culture and makes Giant Tiger a community proud retailer.

 

As one of Canada’s top discount retailers, Giant Tiger is committed to saving Canadians time and money through everyday low prices, an incredible flyer program, ad match guarantee and a focus on exceptional customer service.

1...168169170...388Page 169 of 388

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

© 2026 IHR Magazine | Canada's Natural Health Industry Authority | Le guide de l’industrie canadienne de la santé naturelle